10 results on '"Omar Garcia"'
Search Results
2. GNSS, IMU, camera and LIDAR technology characterization for railway ground truth and digital map generation
- Author
-
Crespillo, Omar Garcia, Kliman, Ana, Neri, Alessandro, Vennarini, Alessia, Ruggeri, Agostino, Marais, Juliette, Arroyo, Juan, Ramírez, María-Eva, Emmanuele, Giusy, and Sabina, Salvatore
- Abstract
Satellite navigation in combination with affordable onboard sensors are key enabling technologies to support the digitalization in railway transport. However, the adoption of these technologies still requires common methodologies to evaluate anywhere the positioning performance. For this, the comparison with a reference ground truth as well as the availability of digital railway maps is necessary. However, the development of a reliable Ground Truth and Digital Map solutions based on affordable onboard sensors requires on its side first a rigorous characterization of each sensor technology. This paper provides with the most important aspects for the characterization of GNSS, IMU, Camera and LIDAR technologies for its use in railway environment within the context of the European RAILGAP project.
- Published
- 2023
- Full Text
- View/download PDF
3. Impact of sex, age, and ancestry on Apolipoprotein E‐APOE‐ risk for Alzheimer's disease.
- Author
-
Rodriguez, Omar Garcia, Young, Juan I., Wang, Lily, Martin, Eden R., and Kunkle, Brian W.
- Abstract
Background: Previous studies have reported that non‐Hispanic White (NHW) females carrying the APOE ε4 allele have an increased risk for developing AD when compared to men. Recently, analyses showed that the risk for developing AD may be equivalent for males and females but may differ by age. Few studies have been done on this issue in groups other than NHW. We aimed to evaluate the association between sex, age, ancestry, APOE, and AD. Methods: We conducted a pooled case‐control study from 45 independent databases in Alzheimer's Disease Genetics Consortium. Individuals (age≥55 years) were included (n = 31,058). Independent variables were age, sex, ancestry/ethnicity, and APOE genotype (ε3/ε4 vs. ε3/ε3). Logistic, linear, and Cox regression models were performed by sex and ancestry. Results: Regardless of ancestry, men and women with APOE ε3/ε4 showed no significant difference in the risk of developing AD (all age groups combined). When comparing subjects with APOE ε3/ε4 to those with ε3/ε3, East‐Asian (EA) females (OR,4.90; 95% CI: 3.46‐6.95) had the strongest OR, followed by EA males (OR, 4.09: 2.67‐6.27); and NHW females (OR,3.40: 3.14‐3.68) and men (OR,3.33: 3.03‐3.66) among all ethnicities. When stratified by age, NHW females (OR, 3.41: 2.69‐4.32 vs. NHW males: OR,2.57: 1.94‐3.39) and EA women (OR,6.51: 1.31‐32.30 vs. EA men: OR,3.41: 0.66‐17.56) with APOE ε3/ε4 showed a higher risk of developing AD between ages 55‐65; whereas African American (AA) women (OR,4.14: 3.06‐5.60 vs. AA men: OR,2.27: 1.45‐3.55) exhibited this pattern later, at the age of 66‐75 years. In Hispanics, the pattern is reversed, with males aged 55‐65 years carrying APOE ε3/ε4 (OR,6.65; 1.64‐26.89: vs. females: OR,2.27; 1.03‐4.98) had a stronger association with AD risk than their female counterpart. Case‐only and survival analyses also showed that NHW and EA female carriers of APOE ε3/ε4 had an earlier age at the onset of AD than their counterpart in men. Conclusions: Our findings suggest sex differences by age and ethnicity in the risk for developing AD and age at onset of AD for carriers of APOE ε4. Confirming these findings could lead to a better‐personalized risk assessment for AD that accounts for sex differences in APOE. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Impact of sex, age, and ancestry on Apolipoprotein E‐APOE‐ risk for Alzheimer's disease.
- Author
-
Rodriguez, Omar Garcia, Young, Juan I., Wang, Lily, Martin, Eden R., and Kunkle, Brian W.
- Abstract
Background: Previous studies have reported that non‐Hispanic White (NHW) females carrying the APOE ε4 allele have an increased risk for developing AD when compared to men. Recently, analyses showed that the risk for developing AD may be equivalent for males and females but may differ by age. Few studies have been done on this issue in groups other than NHW. We aimed to evaluate the association between sex, age, ancestry, APOE, and AD. Methods: We conducted a pooled case‐control study from 45 independent databases in Alzheimer's Disease Genetics Consortium. Individuals (age≥55 years) were included (n = 31,058). Independent variables were age, sex, ancestry/ethnicity, and APOE genotype (ε3/ε4 vs. ε3/ε3). Logistic, linear, and Cox regression models were performed by sex and ancestry. Results: Regardless of ancestry, men and women with APOE ε3/ε4 showed no significant difference in the risk of developing AD (all age groups combined). When comparing subjects with APOE ε3/ε4 to those with ε3/ε3, East‐Asian (EA) females (OR,4.90; 95% CI: 3.46‐6.95) had the strongest OR, followed by EA males (OR, 4.09: 2.67‐6.27); and NHW females (OR,3.40: 3.14‐3.68) and men (OR,3.33: 3.03‐3.66) among all ethnicities. When stratified by age, NHW females (OR, 3.41: 2.69‐4.32 vs. NHW males: OR,2.57: 1.94‐3.39) and EA women (OR,6.51: 1.31‐32.30 vs. EA men: OR,3.41: 0.66‐17.56) with APOE ε3/ε4 showed a higher risk of developing AD between ages 55‐65; whereas African American (AA) women (OR,4.14: 3.06‐5.60 vs. AA men: OR,2.27: 1.45‐3.55) exhibited this pattern later, at the age of 66‐75 years. In Hispanics, the pattern is reversed, with males aged 55‐65 years carrying APOE ε3/ε4 (OR,6.65; 1.64‐26.89: vs. females: OR,2.27; 1.03‐4.98) had a stronger association with AD risk than their female counterpart. Case‐only and survival analyses also showed that NHW and EA female carriers of APOE ε3/ε4 had an earlier age at the onset of AD than their counterpart in men. Conclusions: Our findings suggest sex differences by age and ethnicity in the risk for developing AD and age at onset of AD for carriers of APOE ε4. Confirming these findings could lead to a better‐personalized risk assessment for AD that accounts for sex differences in APOE. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Deep Defect States in Wide-Band-Gap ABX3 Halide Perovskites.
- Author
-
Levine, Igal, Vera, Omar Garcia, Kulbak, Michael, Ceratti, Davide-Raffaele, Rehermann, Carolin, Márquez, José A., Levcenko, Sergiu, Unold, Thomas, Hodes, Gary, Balberg, Isaac, Cahen, David, and Dittrich, Thomas
- Published
- 2019
- Full Text
- View/download PDF
6. Numerical Methods: An Online Course
- Author
-
Carranza, Rogelio Ramos, Márquez, Armando Aguilar, Rodríguez, Frida M. León, León, Omar Garcia, Becerril, Miguel N. Pineda, and Bermúdez, Juan R. Garibay
- Abstract
The purpose of the present investigation is the design and implementation of an on lineNumerical Methods course for the college level (undergraduate), to students from different areas of engineering.
- Published
- 2014
- Full Text
- View/download PDF
7. HUman MicroNucleus project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei
- Author
-
Bonassi, Stefano, Fenech, Michael, Lando, Cecilia, Lin, Yi-ping, Ceppi, Marcello, Chang, Wushou Peter, Holland, Nina, Kirsch-Volders, Micheline, Zeiger, Errol, Ban, Sadayuki, Barale, Roberto, Bigatti, Maria Paola, Bolognesi, Claudia, Jia, Cao, Giorgio, Marina Di, Ferguson, Lynnette R., Fucic, Aleksandra, Lima, Omar Garcia, Hrelia, Patrizia, Krishnaja, Ayyathan P., Lee, Tung-Kwang, Migliore, Lucia, Mikhalevich, Ludmilla, and Mirkova, Ekaterina
- Abstract
Micronucleus (MN) expression in peripheral blood lymphocytes is well established as a standard method for monitoring chromosome damage in human populations. The first results of an analysis of pooled data from laboratories using the cytokinesis-block micronucleus (CBMN) assay and participating in the HUMN (HUman MicroNucleus project) international collaborative study are presented. The effects of laboratory protocol, scoring criteria, and host factors on baseline micronucleated binucleate cell (MNC) frequency are evaluated, and a reference range of normal values against which future studies may be compared is provided. Primary data from historical records were submitted by 25 laboratories distributed in 16 countries. This resulted in a database of nearly 7000 subjects. Potentially significant differences were present in the methods used by participating laboratories, such as in the type of culture medium, the concentration of cytochalasin-B, the percentage of fetal calf serum, and in the culture method. Differences in criteria for scoring micronuclei were also evident. The overall median MNC frequency in nonexposed (i.e., normal) subjects was 6.5 and the interquartile range was between 3 and 12. An increase in MNC frequency with age was evident in all but two laboratories. The effect of gender, although not so evident in all databases, was also present, with females having a 19% higher level of MNC frequency (95% confidence interval: 1424%). Statistical analyses were performed using random-effects models for correlated data. Our best model, which included exposure to genotoxic factors, host factors, methods, and scoring criteria, explained 75% of the total variance, with the largest contribution attributable to laboratory methods. Environ. Mol. Mutagen. 37:3145, 2001 © 2001 Wiley-Liss, Inc.
- Published
- 2001
- Full Text
- View/download PDF
8. HUman MicroNucleus project: international database comparison for results with the cytokinesis‐block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei
- Author
-
Bonassi, Stefano, Fenech, Michael, Lando, Cecilia, Lin, Yi‐ping, Ceppi, Marcello, Chang, Wushou Peter, Holland, Nina, Kirsch‐Volders, Micheline, Zeiger, Errol, Ban, Sadayuki, Barale, Roberto, Bigatti, Maria Paola, Bolognesi, Claudia, Jia, Cao, Di Giorgio, Marina, Ferguson, Lynnette R., Fucic, Aleksandra, Lima, Omar Garcia, Hrelia, Patrizia, Krishnaja, Ayyathan P., Lee, Tung‐Kwang, Migliore, Lucia, Mikhalevich, Ludmilla, Mirkova, Ekaterina, Mosesso, Pasquale, Müller, Wolfgang‐Ulrich, Odagiri, Youichi, Scarffi, Maria Rosaria, Szabova, Elena, Vorobtsova, Irena, Vral, Anne, and Zijno, Andrea
- Abstract
Micronucleus (MN) expression in peripheral blood lymphocytes is well established as a standard method for monitoring chromosome damage in human populations. The first results of an analysis of pooled data from laboratories using the cytokinesis‐block micronucleus (CBMN) assay and participating in the HUMN (HUman MicroNucleus project) international collaborative study are presented. The effects of laboratory protocol, scoring criteria, and host factors on baseline micronucleated binucleate cell (MNC) frequency are evaluated, and a reference range of “normal” values against which future studies may be compared is provided. Primary data from historical records were submitted by 25 laboratories distributed in 16 countries. This resulted in a database of nearly 7000 subjects. Potentially significant differences were present in the methods used by participating laboratories, such as in the type of culture medium, the concentration of cytochalasin‐B, the percentage of fetal calf serum, and in the culture method. Differences in criteria for scoring micronuclei were also evident. The overall median MNC frequency in nonexposed (i.e., normal) subjects was 6.5‰ and the interquartile range was between 3 and 12‰. An increase in MNC frequency with age was evident in all but two laboratories. The effect of gender, although not so evident in all databases, was also present, with females having a 19% higher level of MNC frequency (95% confidence interval: 14–24%). Statistical analyses were performed using random‐effects models for correlated data. Our best model, which included exposure to genotoxic factors, host factors, methods, and scoring criteria, explained 75% of the total variance, with the largest contribution attributable to laboratory methods. Environ. Mol. Mutagen. 37:31–45, 2001 © 2001 Wiley‐Liss, Inc.
- Published
- 2001
- Full Text
- View/download PDF
9. Correction to "Deep Defect States in Wide-Band-Gap ABX3 Halide Perovskites".
- Author
-
Levine, Igal, Vera, Omar Garcia, Kulbak, Michael, Dagar, Janardan, Ceratti, Davide-Raffaele, Rehermann, Carolin, Márquez, José A., Levcenko, Sergiu, Unold, Thomas, Hodes, Gary, Balberg, Isaac, Cahen, David, and Dittrich, Thomas
- Published
- 2019
- Full Text
- View/download PDF
10. Gas-Diffusion Cathodes Integrating Carbon Nanotube Modified-Toray Paper and Bilirubin Oxidase
- Author
-
Omar Garcia, S., Narváez Villarrubia, Claudia, Falase, Akinbayowa, and Atanassov, Plamen
- Abstract
This research introduces the design of a gas-diffusional cathode employing bilirubin oxidase (BOx) immobilized on a complex matrix composed of carbon nanotube (CNT) modified Toray paper (TP) and, encapsulated in silica-gel. The developed enzymatic cathode consists of two layers. One is the hydrophobic gas-diffusional layer (GDL) and the other a hydrophilic catalytic layer (CL) which were combined by pressing at 1000 psi for five minutes. The GDL (35% weight teflonized Vulcan carbon powder (XC35)) that is exposed to air has hydrophobic and porous properties that facilitate oxygen diffusion. The CL consists of a thin, high surface area, 3D CNT/silica-gel matrix where the 3D-enzymatic structure is immobilized and preserved. The nanostructured architecture of the CL was designed to improve conductivity and surface area. Such a design was achieved by modifying the TP surface with CNTs. CNTs are grown on TP by chemical vapor deposition which is possible by electrodepositing Ni seeds via pulse chronoamperometry. Entrapment of BOx was achieved by using tetramethyl orthosilicate (TMOS), a highly volatile compound that results in a polymeric condensation reaction with H2O at room temperature. TMOS polymerization of the cathode surface was performed in a chemical vapor deposition process to form a silica-gel matrix. The gas diffusional cathode was assembled to a capillary driven microfluidic system to be electrochemically characterized. The characterization was performed from electrolyte pH 5 to pH 8 with increments 0.5 in pH. The best performance was observed at pH 5.5 showing a current output of 655.07 ± 146.18 μA.cm−2and 345.36 ± 30.04 μA.cm−2at 0 V and 0.3 V, respectively. At a pH of 7.5 the current generated was 287.05 ± 20.37 μA.cm−2and 205.37 ± 1.57 μA.cm−2at 0 V and 0.3 V, respectively. The results show the stability of the enzymatic structure, subject to various pH, is maintained within the 3D-CNT silica-gel matrix for pH lower than 8. Future work will focus on storage life and stability over time.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.